(Total Views: 500)
Posted On: 11/15/2024 7:21:15 AM
Post# of 148863
Re: KenChowder #148034
I see too that the RECOVER folks are looking for questions and comments during the webinar.
If they don't mention Leron during their presentations, it would be nice if someone more sci-friendly than I am would ask if they are familiar with the results of the Leronlimab Long Covid trial, where 19 of 24 symptoms tested showed improvement.
Quote:
To maximize the number of questions that can be addressed during the webinar, the webinar’s organizers will accept questions and comments ahead of time. Anyone can submit a question by emailing recover-tlc-submissions@nih.gov. Audience members also will be able to pose questions to presenters live during the webinar. This webinar will be recorded and posted online so it can be viewed at later dates.
If they don't mention Leron during their presentations, it would be nice if someone more sci-friendly than I am would ask if they are familiar with the results of the Leronlimab Long Covid trial, where 19 of 24 symptoms tested showed improvement.
(6)
(0)Scroll down for more posts ▼
